Circulating Lymphocyte Subsets Are Associated with Diabetic Kidney Disease and Overall Survival in Patients with Type 2 Diabetes
Open Access
- 21 May 2026
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 14 (5) , 1171
Abstract
Background: The immune mechanism of diabetic kidney disease (DKD) has not yet been fully elucidated. This study aimed to characterize circulating lymphocyte subsets in patients with type 2 diabetes mellitus (T2DM), with a particular focus on DKD-related immune alterations and prognosis. Methods: Circulating T cells, B cells and NK cells were identified by flow cytometry. The primary endpoint was all-cause mortality, and overall survival was defined as the time from enrollment to death from any cause or last follow-up. Associations between lymphocyte subsets, inflammatory indices and renal function parameters were analyzed. Cox regression was used to identify factors associated with overall survival in patients with DKD and in the whole T2DM cohort. A prognostic nomogram was developed in the whole T2DM cohort to estimate 1-, 2-, 3-, and 5-year overall survival (OS) probabilities. Model performance was evaluated using the concordance index (C-index), calibration curves, receiver operating characteristic (ROC) curves, and decision curve analysis (DCA). Mendelian randomization (MR) was performed as a further exploratory analysis to assess whether immune-related traits were genetically associated with DKD susceptibility, with inverse variance weighting (IVW) as the primary analytical method. Results: In total, 74 T2DM patients were divided into DKD (stage 3–4 of chronic kidney disease) and non-DKD groups. Median follow-up duration was 34.6 months. DKD patients exhibited elevated levels of NK cells, the monocyte-to-lymphocyte ratio (MLR), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR). In patients with DKD, higher PLR and serum creatinine (SCr) were associated with poorer overall survival, whereas CD4+CD25+ T cell frequency was not significant after adjustment. In the whole T2DM cohort, higher frequency of circulating CD4+CD25+ T cells were associated with improved survival (HR 0.920, 95% CI 0.858–0.986, p = 0.019), whereas elevated PLR and SCr were linked to poorer outcomes. The exploratory nomogram incorporating CD4+CD25+ T cells, PLR, and SCr, showed acceptable internal performance in this cohort. As a separate exploratory analysis, MR suggested that genetically proxied CD4 expression on activated CD4 regulatory T cells was associated with a lower risk of DKD. Conclusions: DKD was associated with higher mortality and elevated MLR-, NLR-, PLR-, and NK cell levels in patients with T2DM. In patients with DKD, PLR and SCr were associated with overall survival, supporting the prognostic relevance of systemic inflammation and renal dysfunction. Individual lymphocyte subsets were not independently associated with survival in the DKD cohort after adjustment, whereas CD4+CD25+ T cell frequency provided additional prognostic information in the whole extended T2DM cohort analysis. Further validation is warranted.Keywords
Funding Information
- Guangdong Provincial Department of Science and Technology (2024A15150131139)
- Guangdong Provincial Department of Science and Technology (2023B110009)
- National Natural Science Foundation of China (82270780)
- National Natural Science Foundation of China (82470773)
This publication has 37 references indexed in Scilit:
- CD95/Fas and metastatic disease: What does not kill you makes you strongerSeminars in Cancer Biology, 2020
- CD4+CD25+ Tregs as dependent factor in the course of bleomycin-induced pulmonary fibrosis in miceExperimental Cell Research, 2020
- Decreased number of CD19+CD24hiCD38hi regulatory B cells in Diabetic nephropathyMolecular Immunology, 2019
- Clinical observation of the reduced glutathione in the treatment of diabetic chronic kidney diseaseJournal of Cellular Biochemistry, 2018
- Non-genetic mechanisms of diabetic nephropathyFrontiers of Medicine, 2017
- CD28 Costimulation: From Mechanism to TherapyImmunity, 2016
- The alteration of Th1/Th2/Th17/Treg paradigm in patients with type 2 diabetes mellitus: Relationship with diabetic nephropathyHuman Immunology, 2014
- Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD miceJournal of Autoimmunity, 2009
- Uremic toxin and bone metabolismJournal of Bone and Mineral Metabolism, 2006
- The activation antigen CD69Stem Cells, 1994